BioPharma Credit (BPCR) News Today GBX 0.88 0.00 (0.00%) As of 11:52 AM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesBuy This Stock BPCR Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period BioPharma Credit (LON:BPCR) Stock Price Up 0.7% - Time to Buy?July 15 at 2:59 AM | americanbankingnews.comBioPharma Credit (LON:BPCR) Stock Price Up 0.7% - What's Next?July 15 at 2:58 AM | marketbeat.comBioPharma Credit (LON:BPCR) Sets New 52-Week High - Time to Buy?June 23, 2025 | marketbeat.comBioPharma Credit (LON:BPCR) Shares Up 0.4% - Time to Buy?June 17, 2025 | marketbeat.comBioPharma Credit (LON:BPCR) Reaches New 52-Week High - Should You Buy?June 17, 2025 | marketbeat.comBioPharma Credit (LON:BPCR) Trading 0.2% Higher - Time to Buy?May 29, 2025 | marketbeat.comBioPharma Credit (LON:BPCR) Stock Price Down 0.7% - Time to Sell?May 4, 2025 | marketbeat.comBioPharma Credit (LON:BPCR) Hits New 1-Year Low - Should You Sell?April 11, 2025 | marketbeat.comBioPharma Credit (LON:BPCR) Share Price Passes Below 50 Day Moving Average - Time to Sell?April 6, 2025 | marketbeat.comCash in on the biotech sector with specialist trust BioPharmaApril 3, 2025 | msn.comBioPharma Credit (LON:BPCR) Declares Dividend of $0.02March 27, 2025 | marketbeat.comBioPharma Credit (LON:BPCR) Sets New 12-Month High - Time to Buy?March 14, 2025 | marketbeat.comBioPharma Credit (LON:BPCR) Shares Up 0.7% - What's Next?February 25, 2025 | marketbeat.comBioPharma Credit announces dividend payoutJanuary 23, 2025 | msn.comBioPharma Credit's (LON:BPCR) investors will be pleased with their respectable 43% return over the last five yearsJanuary 7, 2025 | finance.yahoo.comInvestors in BioPharma Credit (LON:BPCR) have seen respectable returns of 44% over the past five yearsJuly 31, 2024 | finance.yahoo.comBuy Rating Affirmed for Benitec Biopharma Following Promising BB-301 Trial Results and Financial BoostApril 22, 2024 | markets.businessinsider.comSapna Shah Acquires 20,000 Shares of BioPharma Credit (LON:BPCR) StockMarch 28, 2024 | insidertrades.comBioPharma Credit PLC (BPCP.L)February 26, 2024 | nz.finance.yahoo.comInvestors in BioPharma Credit (LON:BPCR) have seen notable returns of 40% over the past five yearsFebruary 22, 2024 | finance.yahoo.comBiopharma Credit just downgraded at Jefferies, here's whyFebruary 7, 2024 | realmoney.thestreet.comAssessing Ambrx Biopharma: Insights From 7 Financial AnalystsJanuary 9, 2024 | markets.businessinsider.comBioPharma Credit Ord (BPCR.L)January 8, 2024 | finance.yahoo.comBioPharma Credit to fund LumiraDx ahead of acquisition by RocheJanuary 2, 2024 | lse.co.ukBioPharma Credit PLC (LON:BPCR) Looks Interesting, And It's About To Pay A DividendDecember 3, 2023 | finance.yahoo.comTruist Securities Downgrades POINT Biopharma Global (PNT)October 4, 2023 | msn.comBioPharma Credit notes liquidity amendments to LumiraDX loan dealSeptember 19, 2023 | lse.co.ukConnect Biopharma Reports First Half 2023 Financial Results and Provides Business UpdateSeptember 12, 2023 | benzinga.comInvesting in BioPharma Credit (LON:BPCR) five years ago would have delivered you a 19% gainAugust 27, 2023 | finance.yahoo.comLumiraDx Inc: LumiraDx Reports Second Quarter 2023 ResultsAugust 24, 2023 | finanznachrichten.deBest Credit Cards For Recent College Graduates In August 2023August 16, 2023 | forbes.comABVC Biopharma Shares Drop 15% After Big Rise TuesdayAugust 2, 2023 | marketwatch.comCantor Fitzgerald Maintains Reata Pharmaceuticals Inc - (RETA) Overweight RecommendationJuly 25, 2023 | msn.comBest Mobile Credit Card Readers Of 2023July 23, 2023 | forbes.comTD Cowen Initiates Coverage of Reata Pharmaceuticals Inc - (RETA) with Outperform RecommendationJuly 6, 2023 | msn.comDRI Healthcare Trust says CTI BioPharma repaid $54.8M debtJune 26, 2023 | msn.comThis stock could become a 'one-stop shop' for biopharma and rally more than 35%, RBC saysJune 21, 2023 | cnbc.comHear how Cambrian BioPharma is reinventing drug (and drug company) developmentMay 2, 2023 | msn.comBioPharma Credit PLC (LON:BPCR) Passed Our Checks, And It's About To Pay A US$0.018 DividendApril 23, 2023 | finance.yahoo.comBioPharma Credit's (LON:BPCR) investors will be pleased with their notable 42% return over the last three yearsMarch 20, 2023 | finance.yahoo.comAmbrx Biopharma Shares Rise 7% After Completing ATM ProgramMarch 13, 2023 | marketwatch.comThe next big wave of patent cliffs is ahead; expect biopharma M&A to rise – reportFebruary 19, 2023 | msn.comHillstream BioPharma Shares Rise 15% After Licensing DealFebruary 13, 2023 | marketwatch.comBenzinga's Top Ratings Upgrades, Downgrades For February 13, 2023February 13, 2023 | msn.comHillstream BioPharma Shares Soar on Positive Lung Cancer Treatment ResultsFebruary 10, 2023 | marketwatch.comFirst Wave BioPharma Regains Compliance With Nasdaq's Minimum Bid Price RequirementFebruary 7, 2023 | technews.tmcnet.comHillstream BioPharma Shares Double After Option Agreement With Dana-Farber Cancer InstituteJanuary 31, 2023 | marketwatch.comBPCR.L - | Stock Price & Latest News | ReutersJanuary 15, 2023 | reuters.comFirst Wave BioPharma Announces Initial Clinical Sites for its Phase 2 Trial of Enhanced Microgranule Delivery Formulation of AdrulipaseDecember 5, 2022 | technews.tmcnet.comInvestors in BioPharma Credit (LON:BPCR) have made a return of 19% over the past five yearsOctober 1, 2022 | finance.yahoo.com Get BioPharma Credit News Delivered to You Automatically Sign up to receive the latest news and ratings for BPCR and its competitors with MarketBeat's FREE daily newsletter. Email Address BPCR Media Mentions By Week BPCR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BPCR News Sentiment▼1.131.00▲Average Financial Services News Sentiment BPCR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BPCR Articles This Week▼20▲BPCR Articles Average Week Get BioPharma Credit News Delivered to You Automatically Sign up to receive the latest news and ratings for BPCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alliance Trust News abrdn News 3i Infrastructure News Petershill Partners News Burford Capital News JPMorgan Global Growth & Income News RIT Capital Partners News Bridgepoint Group News Monks News Man Group News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:BPCR) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioPharma Credit Please log in to your account or sign up in order to add this asset to your watchlist. Share BioPharma Credit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
